GFR 0 3 0 3 B-clinical_variable
â‰¥ 4 5 4 5 O
40 6 8 6 8 B-lower_bound

Implanted 0 9 9 18 B-treatment
medical 10 17 19 26 I-treatment
device 18 24 27 33 I-treatment
not 25 28 34 37 O
described 29 38 38 47 O
above 39 44 48 53 O
that 45 49 54 58 O
is 50 52 59 61 O
not 53 56 62 65 O
MRI 57 60 66 69 B-treatment
- 60 61 69 70 O
compatible 61 71 70 80 O

Known 0 5 81 86 O
history 6 13 87 94 O
of 14 16 95 97 O
allergic 17 25 98 106 O
reaction 26 34 107 115 O
to 35 37 116 118 O
Magnetic 38 46 119 127 B-allergy_name
Resonance 47 56 128 137 I-allergy_name
contrast 57 65 138 146 I-allergy_name
material 66 74 147 155 I-allergy_name

Known 0 5 156 161 O
history 6 13 162 169 O
of 14 16 170 172 O
claustrophobia 17 31 173 187 B-chronic_disease

Late 0 4 188 192 O
stage 5 10 193 198 O
renal 11 16 199 204 B-chronic_disease
failure 17 24 205 212 I-chronic_disease
with 25 29 213 217 O
estimated 30 39 218 227 B-clinical_variable
glomerular 40 50 228 238 I-clinical_variable
filtration 51 61 239 249 I-clinical_variable
rate 62 66 250 254 I-clinical_variable
( 67 68 255 256 I-clinical_variable
eGFR 68 72 256 260 I-clinical_variable
) 72 73 260 261 I-clinical_variable

No 0 2 262 264 O
contraindications 3 20 265 282 O
to 21 23 283 285 O
getting 24 31 286 293 O
contrast 32 40 294 302 O
enhanced 41 49 303 311 O
MRI 50 53 312 315 B-treatment
examinations 54 66 316 328 O

Non 0 3 329 332 B-language_fluency
- 3 4 332 333 I-language_fluency
english 4 11 333 340 I-language_fluency
speaking 12 20 341 349 I-language_fluency
population 21 31 350 360 O
will 32 36 361 365 O
be 37 39 366 368 O
excluded 40 48 369 377 O
from 49 53 378 382 O
the 54 57 383 386 O
study 58 63 387 392 O
due 64 67 393 396 O
to 68 70 397 399 O
lack 71 75 400 404 O
of 76 78 405 407 O
sufficient 79 89 408 418 O
resources 90 99 419 428 O
to 100 102 429 431 O
pay 103 106 432 435 O
for 107 110 436 439 O
translator 111 121 440 450 O
and 122 125 451 454 O
interpreter 126 137 455 466 O
services 138 146 467 475 O

Patients 0 8 476 484 O
with 9 13 485 489 O
contraindications 14 31 490 507 O
for 32 35 508 511 O
MRI 36 39 512 515 B-treatment
due 40 43 516 519 O
to 44 46 520 522 O
embedded 47 55 523 531 O
foreign 56 63 532 539 O
metallic 64 72 540 548 O
objects 73 80 549 556 O

Patients 0 8 557 565 O
with 9 13 566 570 O
ferromagnetic 14 27 571 584 O
or 28 30 585 587 O
otherwise 31 40 588 597 O
non 41 44 598 601 O
- 44 45 601 602 O
MRI 45 48 602 605 O
compatible 49 59 606 616 O
aneurysm 60 68 617 625 B-treatment
clips 69 74 626 631 I-treatment

Pregnancy 0 9 632 641 B-pregnancy

Regular 0 7 642 649 O
clinical 8 16 650 658 O
practice 17 25 659 667 O
already 26 33 668 675 O
excludes 34 42 676 684 O
pregnant 43 51 685 693 B-pregnancy
patients 52 60 694 702 O
from 61 65 703 707 O
gadolinium 66 76 708 718 O
contrast 77 85 719 727 O
due 86 89 728 731 O
to 90 92 732 734 O
unknown 93 100 735 742 O
effects 101 108 743 750 O
on 109 111 751 753 O
the 112 115 754 757 O
fetus 116 121 758 763 O

The 0 3 764 767 O
current 4 11 768 775 O
clinical 12 20 776 784 O
practice 21 29 785 793 O
will 30 34 794 798 O
be 35 37 799 801 O
applied 38 45 802 809 O
- 46 47 810 811 O
patients 48 56 812 820 O
will 57 61 821 825 O
be 62 64 826 828 O
verbally 65 73 829 837 O
screened 74 82 838 846 O
and 83 86 847 850 O
asked 87 92 851 856 O
if 93 95 857 859 O
they 96 100 860 864 O
think 101 106 865 870 O
they 107 111 871 875 O
could 112 117 876 881 O
be 118 120 882 884 O
pregnant 121 129 885 893 B-pregnancy

The 0 3 894 897 O
presence 4 12 898 906 O
of 13 15 907 909 O
an 16 18 910 912 O
implanted 19 28 913 922 O
pacemaker 29 38 923 932 B-treatment
or 39 41 933 935 O
implanted 42 51 936 945 O
defibrillator 52 65 946 959 B-treatment
device 66 72 960 966 I-treatment

less 0 4 967 971 O
than 5 9 972 976 O
30 10 12 977 979 B-upper_bound
mL 13 15 980 982 I-upper_bound
/ 15 16 982 983 I-upper_bound
min/1.73 16 24 983 991 I-upper_bound
m2 25 27 992 994 I-upper_bound
based 28 33 995 1000 O
on 34 36 1001 1003 O
patient 37 44 1004 1011 O
's 44 46 1011 1013 O
serum 47 52 1014 1019 B-clinical_variable
creatinine 53 63 1020 1030 I-clinical_variable
due 64 67 1031 1034 O
to 68 70 1035 1037 O
the 71 74 1038 1041 O
significantly 75 88 1042 1055 O
increased 89 98 1056 1065 O
risk 99 103 1066 1070 O
of 104 106 1071 1073 O
nephrogenic 107 118 1074 1085 B-chronic_disease
systemic 119 127 1086 1094 I-chronic_disease
fibrosis 128 136 1095 1103 I-chronic_disease
( 137 138 1104 1105 I-chronic_disease
NSF 138 141 1105 1108 I-chronic_disease
) 141 142 1108 1109 I-chronic_disease

